Video Experimental Relacionado
Updated: Mar 7, 2026
06:38
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.6K
¿Cuánto tiempo más vamos a tolerar medicamentos para el cáncer de 100.000 dólares?
Paul Workman1, Giulio F Draetta2, Jan H M Schellens3
1Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK.
Cell
|February 11, 2017
Resumen
El alto costo de los medicamentos contra el cáncer requiere nuevas estrategias. Los socios académicos y comerciales deben colaborar para desarrollar terapias asequibles que salven vidas.
Área de la Ciencia:
- En el campo de la oncología
- Descubrimiento de drogas
- Economía de la salud
Sus antecedentes:
- El coste creciente de las nuevas terapias contra el cáncer constituye un obstáculo importante para el acceso de los pacientes.
- Los modelos de desarrollo de fármacos existentes a menudo resultan en tratamientos inasequibles para muchos pacientes con cáncer.
Objetivo del estudio:
- Proponer un nuevo modelo de colaboración para el descubrimiento de fármacos.
- Abordar el reto de la fijación de precios sostenibles para las terapias innovadoras contra el cáncer.
Principales métodos:
- Este estudio es un análisis conceptual y una propuesta.
- Se aboga por asociaciones estratégicas entre instituciones académicas y entidades comerciales.
Principales resultados:
- Los nuevos marcos de colaboración pueden acelerar el desarrollo de fármacos transformadores contra el cáncer.
- Dichas asociaciones pueden dar lugar a modelos de fijación de precios más sostenibles.
Conclusiones:
- Se necesitan cambios fundamentales en las relaciones de descubrimiento de fármacos.
- La colaboración entre el mundo académico y la industria es crucial para la atención del cáncer asequible.
Más Videos Relacionados
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
6.3K
10:49Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
Published on: June 16, 2022
3.1K
Videos de Conceptos Relacionados
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
02:49Cancer Therapies
10.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K
01:30Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
02:53Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
01:21Cancer Survival Analysis
807
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
807
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K